Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Entera Bio Ltd. - Ordinary Shares
(NQ:
ENTX
)
2.280
-0.010 (-0.44%)
Streaming Delayed Price
Updated: 10:21 AM EST, Dec 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Entera Bio Ltd. - Ordinary Shares
< Previous
1
2
3
Next >
Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session
↗
November 11, 2022
Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program.
Via
Benzinga
Why Missfresh Shares Are Trading Lower; Here Are 30 Stocks Moving Premarket
↗
October 10, 2022
Gainers M-tron Industries, Inc. (NASDAQ: MPTI) rose 57.9% to $24.00 in pre-market trading after surging 10% on Friday. M-tron Industries completed its earlier announced separation from The LGL Group,...
Via
Benzinga
Entera Bio: Q2 Earnings Insights
↗
August 11, 2022
Entera Bio (NASDAQ:ENTX) reported its Q2 earnings results on Thursday, August 11, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Entera Bio Outlines Pivotal Osteoporosis Trial, Names New CEO
↗
July 18, 2022
Via
Benzinga
121 Stocks That Hit Their 52-Week Low
↗
October 14, 2022
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.
Via
Benzinga
Recap: Entera Bio Q1 Earnings
↗
May 12, 2022
Entera Bio (NASDAQ:ENTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Recap: Entera Bio Q4 Earnings
↗
March 08, 2022
Entera Bio (NASDAQ:ENTX) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022
↗
September 06, 2022
Upgrades
Via
Benzinga
$5.1 Million Bet On Tabula Rasa HealthCare? 3 Penny Stocks Insiders Are Buying
↗
July 26, 2022
US crude oil futures traded higher by around 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
↗
July 22, 2022
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period...
Via
Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
↗
July 18, 2022
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least...
Via
Benzinga
82 Biggest Movers From Yesterday
↗
June 15, 2022
Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tuesday.
Via
Benzinga
41 Stocks Moving In Tuesday's Mid-Day Session
↗
June 14, 2022
Gainers Revlon, Inc. (NYSE: REV) rose 125.5% to $2.6499. Revlon’s stock dropped sharply on Monday after the company is reportedly expected to file for bankruptcy.
Via
Benzinga
Follow the Insiders and Buy the Dip in These 3 Stocks
↗
May 06, 2022
These three biotech companies have all had insiders buying shares recently. That's a good sign for the future of their treatments.
Via
InvestorPlace
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
↗
April 08, 2022
Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now.
Via
InvestorPlace
4 Penny Stocks Insiders Are Buying: Crexendo, Performant Financial And More
↗
January 20, 2022
Silver prices surged above $24 per troy ounce for the first time in more than two months and investors also focused on some notable insider...
Via
Benzinga
5 Penny Stocks Insiders Are Buying
↗
January 19, 2022
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...
Via
Benzinga
Entera Bio's Formulated Human Parathyroid Hormone Shows Encouraging BMD Data
↗
October 06, 2021
Entera Bio Ltd (NASDAQ: ENTX) has presented the 6-month bone mineral density (BMD) data from its Phase 2 trial of EB613, an oral formulation of human parathyroid...
Via
Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
↗
October 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...
Via
Benzinga
Neurodegenerative Disease And Cancer Stocks Among Top Biotech Gainers In 2021
↗
July 04, 2021
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF IBB advancing about 8% year-to-date compared to the roughly 14% gain for the S&P...
Via
Talk Markets
Topics
Stocks
Earnings Scheduled For August 16, 2021
↗
August 16, 2021
Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to...
Via
Benzinga
Neurodegenerative Disease, Cancer Stocks Among Top Biotech Gainers In 2021
↗
July 04, 2021
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) advancing about 8% year-to-date ...
Via
Benzinga
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
↗
June 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
45 Biggest Movers From Yesterday
↗
June 24, 2021
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613. First...
Via
Benzinga
Where Might Entera Bio Stock End Up After Rallying Wednesday
↗
June 23, 2021
Entera Bio Ltd (NASDAQ: ENTX) shares rallied higher Wednesday after the company announced it saw positive results from its final six-month bone mineral density results from...
Via
Benzinga
ENTX Stock: The Huge FDA News Sending Entera Bio Soaring
↗
June 23, 2021
Today, investors in ENTX stock are seeing gains of approximately 40% as the company announced results from one of its clinical trials.
Via
InvestorPlace
Mid-Afternoon Market Update: Patterson Companies Drops On Earnings Miss; Entera Bio Shares Gain
↗
June 23, 2021
Toward the end of trading Wednesday, the Dow traded down 0.08% to 33,918.98 while the NASDAQ rose 0.16% to 14,276.41. The S&P also rose, gaining 0.05% to 4,248.47. The U.S....
Via
Benzinga
Topics
Stocks
Nasdaq Notches Intraday High, SPX Eyes Third-Straight Win
↗
June 23, 2021
The Dow Jones Industrial Average is modestly lower this afternoon, walking back this morning's gains to register a 19-point drop.
Via
Talk Markets
Topics
Stocks
Why Entera Bio, Orphazyme, Bellerophon Are Moving Today
↗
June 23, 2021
Entera Bio Ltd. (NASDAQ: ENTX), Orphazyme A/S (NASDAQ: ORPH) and Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) are among the biggest biopharma movers Wednesday. Entera Bio Climbs...
Via
Benzinga
Why Entera Bio Shares Are Skyrocketing Today
↗
June 23, 2021
Entera Bio Ltd (NASDAQ: ENTX) shares are trading higher by 47.66% at $6.63 Wednesday after the company announced the topline Phase 2 clinical trial of EB613 met its primary...
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.